Vortioxetine Hemihydrobromide Orally Disintegrating Tablets

DRUG2 trials

Sponsors

Seasons Biotechnology (Taizhou) Co., Ltd.

Conditions

Major Depressive Disorder (MDD)

Phase 1

Single Dose Oral Bioequivalence Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets

CompletedNCT05417087

Seasons Biotechnology (Taizhou) Co., Ltd.Major Depressive Disorder (MDD)

Start: 2022-06-27End: 2022-09-02Updated: 2023-04-13

Food Effect Bioavailability Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets

CompletedNCT05416957

Seasons Biotechnology (Taizhou) Co., Ltd.Major Depressive Disorder (MDD)

Start: 2022-09-18End: 2022-10-27Updated: 2023-04-13